Position in ALKS
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$2,124,924
-$30,869 QoQ
Shares Held
40,552
-33.5% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#172
of 421 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ALKS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026INTECH INVESTMENT MANAGEMENT LLC holds $75,544,237 across 33 Drug Manufacturers - Specialty & Generic names. ALKS ranks #8 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
474,709 | $16,083,140 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
29,102 | $15,768,335 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
63,662 | $10,729,593 | |
| 4 | LNTH |
Lantheus Holdings, Inc.
|
44,458 | $4,932,170 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
107,818 | $4,423,772 | |
| 6 | ZTS |
Zoetis Inc.
|
60,226 | $4,327,839 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
35,018 | $2,898,790 | |
| 8 | ALKS |
Alkermes plc.
This page
|
40,552 | $2,124,924 |
All Filings in ALKS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,124,924 | 40,552 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $2,155,793 | 60,967 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $4,465,076 | 159,581 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $2,221,110 | 74,037 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,423,524 | 84,709 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $2,825,323 | 85,564 | Shares | Sole | 2025-05-20 | |
| 2024-12-31 | $1,960,022 | 68,151 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $1,463,121 | 52,273 | Shares | Sole | 2024-11-08 | |
| No filing history on record for this holder in this stock. | ||||||